COVID-19 vaccine (St. Petersburg Research Institute of Vaccines and Serums)

N/A

Report date: 2025/01/26 19:30:10

Base Information

Drug NameCOVID-19 vaccine (St. Petersburg Research Institute of Vaccines and Serums)

Drug Alias Namerecombinant protein subunit vaccine (Saint Petersburg Research Institute of Vaccines and Serums)

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSt Petersburg Research Institute of Vaccines and Sera

China Registration ClassN/A

Develop Information

Active CompaniesSt Petersburg Research Institute of Vaccines and Sera

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A